Back To: Home



June 6-7, 2013
European Lab Automation - Hamburg, Germany

June 12-15, 2013

More Events
Name:
Company:
Email:
 
 
 
The LightCycler® 1536 System. Enabling endogenous gene expression.

Medicyte, PRIMACYT to develop hepatocytes
April 2012
SHARING OPTIONS:

HEIDELBERG, Germany—Medicyte and PRIMACYT recently received a $393,000 grant from the BMBF for the development of culturing methods of human hepatocytes for use in cell-based therapies. The upcyte technology from Medicyte enables the expansion of human primary liver cells to large amounts with consistent quality, producing hepatocytes that are functionally equivalent to human primary liver cells and suitable for use in cell-based bioartificial liver systems. Cell-based therapies and transplantable bioartificial livers often fail due to a lack of cells of appropriate quantities and quality. The two companies will work to develop modified liver cells in large amounts in a project support by a University of Tübingen team led by Prof. Andreas Nüssler.
 
“We believe the partnership … creates an ideal opportunity for our two companies to improve bioartificial liver devices,” said Dr. Dieter Runge, managing director of PRIMACYT.

Back

cISBIO

Tecan


Beckman

ISSCR

Drummond

INDIGO
CONTACT US
Drug Discovery News
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2013 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.